Browse All
Displaying 1 - 1 of 1
Author:Cree, Bruce A. C. Danese, Silvio Wolf, Douglas C. Alekseeva, Olga Charles, Lorna Petersen, AnnKatrin Sheffield, James K. Cheng, Chun-Yen Riolo, Jon V. Silva, Diego Lublin, Fred D. Rubin, David T. Cohen, Jeffrey A.
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.007
Author Institution:Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA Humanitas University, Milan, Italy, Milan, Italy Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, Atlanta, GA Nizhegorodskaya Regional Clinical, Nizhegorodskaya oblast' Russia, Nizhegorodskaya oblast' , Russian Federation Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Mount Sinai Medical Center, New York, New York, New York, NY University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, Chicago, IL Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH
